EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Amniotomy versus Deferral at ≥4cm during Standardized Induction of Labor: A Propensity Score-Matched Study

Emily G. Gleason, Lisa D. Levine, Rebecca F. Hamm

American Journal of Perinatology · 2026-11 · 43 (15) · 2111-2114

DOI: 10.1055/a-2867-9266 ↗
AbstractBibliografische Angaben

Abstract

The present study aimed to determine the specific impact of artificial rupture of membranes (AROM) at first examination ≥ 4 cm versus deferring AROM at that examination while undergoing otherwise standardized labor induction. This is a secondary analysis of a prospective cohort evaluating the implementation of standardized induction of labor (IOL) management of patients undergoing ≥37 weeks of induction at two sites from 2018 to 2022 with a singleton pregnancy, intact membranes, and an unfavorable cervix without prior cesarean delivery (CD). Patients were grouped by whether AROM was performed at the first examination ≥4 cm, or deferred. A 1:1 propensity score matching balanced parameters associated with AROM at the ≥4 cm examination. The primary outcome was time to delivery. Secondary outcomes included length of each stage, CD, and maternal/neonatal morbidity. Time-to-event regression analyses for labor length, censored for CD, were modeled with a Cox proportional hazard model. Among 8,509 inductions in the parent study, 5,784 (67.0%) remained unruptured by the first examination ≥4 cm. After propensity score matching, 1,412 were included (n = 706/group). Overall, AROM was associated with shorter time to delivery compared with deferral at first examination ≥4 cm (21.4 [14.6–29.3] vs. 22.6 hours [16.4–31.3]), p = 0.002), a finding consistent across parity. Once censored for CD, these findings remained significant (hazard ratio [HR] = 1.17, 95% confidence interval [CI]: [1.04–1.31]). There were no differences in CD or morbidity. Even when matching for the induction course prior to the first examination at ≥4 cm, AROM at ≥4 cm is associated with shortened time to delivery without increasing maternal or neonatal morbidity.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →